Bell Ceremonies

Rapport Therapeutics Rings the Nasdaq Stock Market Closing Bell

Published

Rapport Therapeutics (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Abraham N. Ceesay, CEO of Rapport Therapeutics, and David Bredt, M.D., Ph.D., Founder and Chief Scientific Officer of Rapport Therapeutics, ring the Closing Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now